Peer review is a part of the process required to get a paper published in a scientific journal. The paper is sent to others around the world who work in your field, who analyse the data and scrutinise it in detail.
Only after this has occurred is a paper accepted to a journal and published - at which point it appears on pubmed.
Again, those 1052 results are not all to do with MSB's studies. They refer to studies performed by hundreds of groups, in relation to anything involving a type of stem cell discovered in 1924.
MSB have published data - there are links from their website. But none of that data involves human trials.
setting the record straight, page-5
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |